PHARMACOVIGILANCE AND RISK MANAGEMENT CONSIDERATION FOR RARE DISEASE GENE THERAPIES

July 17, 2019

The development of a pharmacovigilance and risk management system to support a gene therapy for a rare genetic disease requires consideration of the specific challenges and nuances that novel therapies present throughout the lifetime of the product.

Spotlight

Fort Dodge Animal Health

Fort Dodge Animal Health began in 1912 as a small serum manufacturer based in Fort Dodge, Iowa. Today, the company is headquartered in Overland Park, Kan., and has emerged as a leading global manufacturer of animal health products for the livestock, companion animal, equine, swine, and poultry industries. Fort Dodge is a committed partner to veterinary practitioners, livestock producers, and pet owners worldwide, and is dedicated to meeting their needs and making a difference in the future of animal health.

OTHER WHITEPAPERS
news image

National Council for Prescription Drug Programs

whitePaper | May 12, 2022

This document is Copyright © 2022 by the National Council for Prescription Drug Programs (NCPDP). It may be freely redistributed in its entirety provided this copyright notice is not removed.

Read More
news image

Shining a Light on Lipid Nanoparticle Characterization

whitePaper | October 3, 2022

Next-Generation Synthetic Biology Workflow Platform Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences.

Read More
news image

Ultrasafe film Ultra-high barrier Product stability Patient safety

whitePaper | December 22, 2022

Every viable pharmaceutical packaging system must comprise materials proven to protect its contents against moisture and other atmospheric variables, and be safe for use with the specified dosage form and the route of administration1

Read More
news image

Expediting early-phasedevelopment ofsmall molecules: Anintegrated approach

whitePaper | November 18, 2022

Small molecule drug development has changed substantially in recent years. With the heightened focus on molecularly targeted therapies, small molecule active pharmaceutical ingredients (APIs).

Read More
news image

AI Powered Business Intelligence for Life Science Leaders: Save Time, Drive Adoption and Scale Faster

whitePaper | February 20, 2023

Once the industry has normalized after a turbulent 2020, life sciences leaders can still count on continued change. The future will be challenging at best without the support of next-gen BI as life sciences navigate their businesses through new or growing competition, economic recovery, regulatory and political pressures, barriers to market access, and an increased demand for personalized medicine.

Read More
news image

Sales coaching: preparing for the new reality in pharma

whitePaper | October 14, 2022

COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessment.

Read More

Spotlight

Fort Dodge Animal Health

Fort Dodge Animal Health began in 1912 as a small serum manufacturer based in Fort Dodge, Iowa. Today, the company is headquartered in Overland Park, Kan., and has emerged as a leading global manufacturer of animal health products for the livestock, companion animal, equine, swine, and poultry industries. Fort Dodge is a committed partner to veterinary practitioners, livestock producers, and pet owners worldwide, and is dedicated to meeting their needs and making a difference in the future of animal health.

Events